<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">
Log In

SmartTRAK Life Sciences News and Analysis Blog

3 min read

OSET 2025: Spotlight on OSSIO Kneebar Procedure

By Andy Knapik on 10/2/25 9:53 AM

Dr. Brian Cole discusses the novel OSSIO Kneebar procedure in an interview with SmartTRAK at OSET 2025 in Las Vegas. 

Brian Cole, MD, orthopedic surgeon and sports medicine specialist at Rush Health System, discussed the OSSIO Kneebar procedure for the management of subchondral insufficiency fracture of the femur and tibia, utilizing the bio-integrative OSSIOFiber 4.0mm Cannulated Trimmable Fixation Nail, in an interview with SmartTRAK at the Orthopaedic Summit (OSET) 2025 Annual Meeting held September 18-25, 2025 in  Las Vegas, NV.

To find out more about the OSSIO Kneebar procedure and what makes it so revolutionary, click on the following video (11:49 min). A link to download a complete transcript of the interview is also provided below. 


Interview Transcript

Hi everybody, it's Andy Knapik with SmartTRAK. I'm here at the OSET meeting in Las Vegas and I'm joined with Dr. Brian Cole. Thanks for joining me today.

Dr. Brian Cole: 
Thanks for having me, Andy.

Yes. I've talked a lot in the past about OSSIO. They have some really great products and one of the products that's out now, it's called KneeBar. It's a very unique product. So I thought it'd be great if you, being so involved with the product, you could walk through it and tell us about it.

BC
: Yes, so for clarity, KneeBar is probably what we would say the procedure, I guess is a KneeBar procedure.

Okay.

BC
: The device itself is OSSIO fiber, so it's their core technology, which is I'd say bio-talented, bio-replaceable and gets replaced and/or turns into bone over time. So we know that's the construct for OSSIO fiber, and the device itself is a cannulated trimmable fixation nail.

So the KneeBar procedure basically is a procedure that will address ...

Want to learn more about the novel OSSIO Kneebar procedure? Click the button below to download and read the complete transcript of SmartTRAK's interview with Brian Cole, MD, conducted by  Andy Knapik, SmartTRAK Sr. Analyst, Soft Tissue & Arthroscopic Technologies.Get the Transcript

Topics: Orthopedics
Continue Reading
2 min read

SmartTRAK Announces Retirement of Susan Paquette, Former VP/GM of Wound Care

By Sharon O'Reilly on 9/30/25 11:45 AM

It is with both gratitude and admiration that we announce the retirement of Susan Paquette, our former VP/GM of SmartTRAK Wound Care, after nearly 15 years of dedicated service to SmartTRAK. 

Since joining the company, Susan has been instrumental in building SmartTRAK Wound Care into the industry’s most trusted source of real-time market intelligence. Under her leadership, the Wound Care business has grown from a promising vision into a powerhouse platform providing comprehensive data, news, and analysis on a range of Advanced Wound Care markets. Today, SmartTRAK Wound Care delivers deep coverage across nine distinct areas with broad global reach, relied upon daily by the world’s top wound and orthopedic companies.

Topics: Wound Care
Continue Reading
3 min read

Orthobiologic Care: Inside the Agenda at TOBI Conference 2025

By David Shepard on 9/30/25 9:30 AM

Dr. Steve Sampson, founder of The Orthopedic Institute (TOBI) and the Orthohealing Center, discusses the evolution of orthobiologics, highlighting the integration of machine-based therapies like shockwave and a focus on patient safety, with patients traveling overseas for untested biologic treatments. 

In this interview with SmartTRAK, TOBI founder Steve Sampson, DO, discusses the development of orthobiologics, highlighting a key inflection point where technologies like shockwave and light therapy are used to boost the body's natural healing process. Dr. Sampson also mentions patients traveling abroad for treatments. He warns about the lack of regulatory oversight, potential complications and offers solutions through the Orthohealing Alliance.

Click on the following video (11:10 min) to learn more. A link to download a complete transcript of the interview is provided below.


SmartTRAK: My name is David Shepard. I'm with SmartTRAK, and I'm here at the 16th annual TOBI meeting. and it's my pleasure to be joined by Dr. Steve Sampson. Thanks so much for taking the time. I really appreciate it.

Steve Sampson, DO: Thanks for having me. Looking forward to chatting.

Absolutely. So, the agenda of this year's conference is... It's got a wide range of topics. What do you think is reflected in this year's agenda that really typifies the technologies that are happening out there in the field today?

SS: It's probably the most exciting time in my 20-year career that I feel like we're at this inflection point with new technologies, including machine-based therapies. So, the concept is the human body is remarkable, and we're made of 37 trillion cells, and we have our own drug store, our own ability to self-repair. Our role as physicians is to try to facilitate that. So, machine-based treatments are a big point of this conference where there's a session on shockwave therapy, photo-biomodulation light therapy, hyperbaric oxygen. They're all different machine-based treatments that are trying to boost our body's healing capacity. Then I also have a new session of mesenchymal stem cells or MSCs overseas.

SS: A lot of times, in clinic, we find patients are going to Mexico, Panama, Thailand, and some of them have unlimited resources, but they may not be getting the best level of care and bigger isn't always better.

Right.

SS: So, understanding what are some of the regulatory challenges here in the United States, why are patients going overseas ,,,

Click the button to get the full transcript of our exclusive interview with TOBI founder Steve Sampson, DO, conducted by David Shepard, SmartTRAK GM/Sr Analyst, Orthobio & Regen.Get the Transcript

Continue Reading
2 min read

Navigating Tomorrow's Foot and Ankle Market

By Natasha Weeks on 9/23/25 9:30 AM

Gregory Berlet, MD, shares insights on trends in foot and ankle surgery, including MIS, ASCs, orthobiologics, and AI planning, in an interview with SmartTRAK.

Continue Reading
3 min read

Join the SmartTRAK Team! We're Hiring!

By Thomas Wallick on 9/23/25 9:20 AM

Are you passionate about healthcare and market research? SmartTRAK is looking for talented, self-motivated individuals to join our team. We're currently seeking a Junior Analyst for our Wound Market team and a part-time Compression Market Analyst. These are fantastic opportunities for skilled professionals to contribute to a leading provider of market data and business intelligence in the MedTech industry.

Junior Analyst, Wound Market 

The ideal candidate for this full-time remote role has strong analytical and writing skills and a keen interest in the wound care sector. As a Junior Analyst, you will be a key part of the Wound Market team, helping to track and analyze the latest developments in wound care.

Your responsibilities will include:

  • Collecting and analyzing market data, clinical trial information, and regulatory filings.
  • Drafting market updates, news briefs and insights for our subscribers.
  • Assisting senior analysts with research and strategic reports.
  • Maintaining SmartTRAK's content and databases for the wound market.Learn More and Apply

Compression Market Analyst 

We are also looking for a dedicated professional to fill a part-time remote position as a Compression Market Analyst. This role is perfect for someone with strong knowledge of the global Compression Therapy space, including bandaging, hosiery, and Lymphedema pumps. You will be responsible for providing expert insights and analysis on this dynamic market.

Your responsibilities will include:

  • Maintaining and updating the Compression module, including market models and company profiles.
  • Writing concise articles and market updates for subscribers.
  • Supporting our sales and marketing teams with your expertise.
  • Attending industry conferences to report on new trends and topics.Learn More and Apply


Why Join the SmartTRAK team?

At SmartTRAK, we value a strong work ethic and a collaborative spirit. If you're a self-starter with a passion for MedTech, we encourage you to apply. Don't miss out on these opportunities to grow your career with a leading name in the industry.

  • Work remotely with flexible hours.
  • Gain visibility in the MedTech community through published insights and event coverage.
  • Join a collaborative team of analysts, marketers and data experts. 

To learn more and apply, visit the original job postings:

Continue Reading
2 min read

TendoNova: Revolutionizing Tendinopathy Care

By David Shepard on 9/16/25 9:30 AM

In an interview with SmartTRAK, TendoNova's National Sales Director, Ben Browne, discusses the TendoNova device, a minimally invasive percutaneous tool for treating refractory tendinopathy.

In this SmartTRAK interview, National Director of Sales Ben Browne shares his insights on the TendoNova device, a minimally invasive tool for treating refractory tendinopathy through soft tissue fragmentation and debridement that can also be combined with orthobiologics like platelet-rich plasma (PRP). Click on the following video to learn more (08:37 min). A link to download a transcript of the complete interview is also provided below.


SmartTRAK: Hi, this is David Shepard with SmartTRAK. I'm here with Ben Browne, national sales director for TendoNova. Ben, tell me a little bit about the product and how things are going at the booth today.

Ben Browne: So, it's a great conference, very active, most of the conference so far. And TendoNova is essentially a device that providers are going to use, perhaps instead of or in addition to orthobiologics, to treat a common refractory tendinopathy patient. A patient who's perhaps failed conservative therapies, they've dealt with tendinopathy or tendinosis for at least three months, in some cases, many months. And once again, they failed many conservative therapies. What's great about TendoNova is that ..

Click the button to get the full transcript of our exclusive interview with TendoNova's National Sales Director Ben Browne conducted by David Shepard, SmartTRAK GM/Sr Analyst, Orthobio & Regen.Get the Transcript

Continue Reading
2 min read

Novel New Implant for Massive Irreparable Rotator Cuff Tears: Reach Orthopaedics

By Andy Knapik on 9/9/25 9:30 AM

Christina Goudy, co-founder and CEO of Reach Orthopaedics, discusses the company and its new subacromial spacer device in an interview with SmartTRAK.

In a recent interview with SmartTRAK, Christina Goudy, co-founder and CEO of Reach Orthopaedics, discussed the company’s new subacromial (SA) spacer for the treatment of massive, irreparable rotator cuff tears, its strategic direction and company highlights.

To find out more about the company, its differentiated technologies, products and growth strategy, click on the following video (26:57 min). Interview topics by timecode are provided below, as is a link to download a complete transcript of the interview.


Interview Outline by Timecode:

  • 00:50  Introduction to Reach Orthopaedics and Christina Goudy.
  • 03:15  Image of SA spacer device.
  • 07:05  Christina’s background and running a med device startup.
  • 14:48  Age of the company, FDA pathway and funding.
  • 18:16  Goal for sales to start.
  • 19:42  What the surgeons are saying about the device, specs and sizes.
  • 23:40  Exit strategy.

Click the button below to download and read the complete transcript of SmartTRAK's interview with Christina Goudy, co-founder and CEO of Reach Orthopaedics, conducted by  Andy Knapik, SmartTRAK Sr. Analyst, Soft Tissue & Arthroscopic Technologies.Get the Transcript

Continue Reading
3 min read

Innovation Flourishes Despite the Shadow of Reimbursement Changes: AWC Summit 2025

By Jay Merkel on 9/2/25 9:45 AM

SmartTRAK reports from Boston, where discussions about the future of wound care were distracted by significant changes to reimbursement.

Topics: Wound Care
Continue Reading
3 min read

Ongoing Evolution in Regenerative Medicine

By David Shepard on 8/26/25 9:30 AM

Randy B. Miller, MD shares insights on the history and current state of regenerative medicine, regulatory changes and the influence of technologies like PRP and adipose tissue in an interview with SmartTRAK.

In an interview with SmartTRAK, Randy B. Miller, MD, founder of the American College of Regenerative Medicine, clinical professor in the Division of Plastic Surgery at the University of Miami, and member of the Physician’s Council for the American Association of Tissue Banks, shares his insights on the history and current state of regenerative medicine across various practice areas, focusing on the effects of regulatory changes and the influence of technologies like platelet-rich plasma (PRP) and adipose tissue. 

To find out more, click on the following video (26:33 min). Interview topics by timecode and a link to download the complete transcript of the interview are provided below.

 

Interview Outline by Timecode:

00:16 The early stages of regenerative medicine using adipose tissue and translating experience across different fields of medicine.

02:58 The evolution of the design of adipose recovery cannulas based on application and indication.

07:42 Overview of the 21st Century Cures Act, The Right to Try Act, and the new Florida bill, which impacts regenerative medicine. 

17:34 Recent changes in how we think about the ideal form of PRP.

21:20 Other components in plasma that may have a role in improving PRP.

22:40 Combining the benefits of nanofat and PRP in practice.

24:16 Use of PRP and adipose in combination to resolve scars and how these results match internal fibrosis resolution in COVID cases. 

Discover the latest insights into the evolution of Regenerative Medicine. Click the button to get the full transcript of our exclusive interview with Dr. Randy B. Miller, founder of the American College of Regenerative Medicine conducted by David Shepard, SmartTRAK GM/Sr Analyst, Orthobio & Regen.Get the Transcript


SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s proprietary methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK has to offer and see how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.

Continue Reading
5 min read

Meet the Expert: Thom Clark, Senior Director, Enterprise Strategy + Solutions

By Thomas Wallick on 8/22/25 10:04 AM

We are pleased to announce that Thom Clark has joined the SmartTRAK team as Senior Director, Enterprise Strategy + Solutions. Thom Clark joins us after successful positions in Medtech, Life Science and SaaS enterprise strategy, marketing and customer success.

Thom started his career in the diabetes care industry before being hired by Synthes USA. After a successful stint as both a trauma consultant, then regional manager, Thom moved into solutions and services (consulting) first within the Depuy-Synthes Advantage franchise, then Solutions Innovation,  and finally with JNJ's umbrella Medtech Strategic Customer Group (SCG). Working with the Top 150 health systems, Thom and his team of Directors delivered a broad suite of solutions including operative efficiency, clinical pathway improvement, clinician wellbeing, supply chain management, and patient navigation. After leaving JNJ in 2020, Thom moved to running US Orthopedic Marketing + Solutions at Pacira, then as chief strategy and customer officer for Elation, a human performance and coaching SaaS startup based in Wyoming. Thom and his family reside in the greater Philadelphia area.

Meet Thom Clark:

What is your role with SmartTRAK? As Senior Director, Enterprise Strategy + Solutions, my role as I initially see it is to help both product and commercial strategy in the core ortho solutions portfolio while contributing to SmartTRAK’s overall go-to-market success. As I become more familiar with the people, culture and solutions, I plan to be a catalyst working cross-functionally to help different teams across the organization, including marketing, messaging, contracting, content, research, and consulting – having some experience in each of these functions. Ultimately, it's all about our customers.

What do you like about SmartTRAK? I would have to say the amazing People and the concept of Insights-as-a-Service vs the normal SaaS offering. During the interview process, all my questions were focused on people, culture, innovation, and marketplace. I am also super stoked to begin working with many of my former colleagues in Medtech and Life Science.

What is something special or unique that you bring to SmartTRAK subscribers?
I have a unique history, having moved from sales and sales management to health system consulting in the orthopedic market, focused on TJA and Trauma. Starting with clinical pathway improvement and moving to operational efficiency, supply chain improvement, clinician wellbeing and burnout, patient navigation, and digital surgery, our team under the umbrella of JNJ’s Strategic Customer Group had the privilege of working with the top 100 health systems across the US and even OUS. I also worked in Life Sciences at Pacira and then a human and team performance and coaching SaaS startup business called Elation. I believe I bring a very different view on how unique and powerful data and insights can be leveraged for success. It's also fun to understand both industries from a data and insights perspective.

How/why did you get into the life sciences industry? After college, I was blessed to get into the diabetes market and then hired by Synthes as a trauma rep, then regional manager, health system consulting director, and finally running a national consulting team. I learned very early in my career at Synthes the huge impact you can make on patient outcomes and health system efficiency. I was hooked! I have always been fascinated by how things work and being in orthopedics was a dream come true! Now I get to see the entire industry through a different lens.

What are your favorite online websites or resources that you check every day? Well, I know I need to say SmartTRAK first! As I move back into MedTech and Life Science, my focus will be on connecting (and reconnecting) with my network to conduct research on all the market and product channels we now cover. So many blogs, posts, websites, interviews and industry publications fill my day it would be impossible to list them all. 
 
How do you stay current on what’s going on in the industry? There is absolutely nothing that compares to talking to real humans working on real products, marketing plans, and strategy across the industry. As stated, I am really excited to begin my outreach to “interview” as many people as I can virtually or at shows as part of my enterprise role. Combining this with the amazing amount of experience across our team of analysts at SmartTRAK should be more than adequate.

If you could have one superpower, what would it be? I try to live in “reality” as much as possible, so this one is difficult. I would say the ability to sustain a positive and optimistic mindset, regardless of what life throws at me. I know people who possess this trait and am in awe of their ability to weather hardships and remain cheerful and supportive with a growth mindset.

What was the last show you binge-watched? Wow, probably The Office with my 20 year old during his summer break from the University of Scranton (of all places!).

What is your life like outside of SmartTRAK? Married for 25 years to my best friend, supporter, and confidant. We have two boys, Ben (22) and Harrison (20) and two crazy labradoodles, Bentley and Scarlett, who pretty much run the household. I am a human performance nerd who focuses a lot of time on movement, nutrition, healthspan, and ways to optimize physical and mental well-being. I also love to fly-fish, cycle, and work in the yard.  I am a certified financial and retirement coach and in the process of obtaining personal training and nutritional coach certifications to help others reach their goals and redefine what the term "wealthy" means.

What are you most excited about for your upcoming year at SmartTRAK? The ability to get back to my roots in MedTech and Life Science while quickly learning our product and process to make a noticeable impact on our client's market success in the shortest time possible. Always up for a challenge!

If you'd like to learn more about SmartTRAK and how it can increase proficiency, improve productivity and reduce costs for your company, or if you would like to meet with Thom, just click the button below.

Continue Reading
  • There are no suggestions because the search field is empty.

Recent Articles